Stocks in play: Purepoint Uranium Group Inc.
Announced the closing of its previously announced non-brokered private placement. In connection with the closing, the Company issued 48,642,857 flow-through units at a price of $0.07 per unit for aggregate gross proceeds of $3,405,000. Each Flow-Through Unit consists of one common share in the capital of the Company issued on a "flow through" basis pursuant to the Income Tax Act (Canada) and one half of a common share purchase warrant. Each whole warrant entitles its holder to purchase one common share in the capital of the Company at an exercise price of $0.105 per share for a period of 24 months from the date of issuance. Purepoint Uranium Group Inc. shares V.PTU are trading up $0.01 at $0.07.
Read:
Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates
Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America